Agoracom Blog Home

Posts Tagged ‘Binovi Touch’

Binovi $VISN.ca $BNVIF to Acquire Computer Aided Vision Therapy (CAVT) $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 5:53 PM on Friday, April 16th, 2021
  • Entered into an arm’s length share purchase agreement with the shareholders of Samurai Motion Tracking Corp. whereby the Company has agreed to acquire all of the issued and outstanding share capital of Samurai
  • Acquisition demonstrates Binovi’s commitment to continually evolve our technology offering with adoptable resources to SaaS stack

VANCOUVER, BC / April 16, 2021 / Binovi Technologies Corp. (“Binovi” or the “Company’) (OTCQB:BNVIF) (TSX-V:VISN) (GR:2EYA) a leader in neuro-vision performance technology, is pleased to announce that it has entered into an arm’s length share purchase agreement (the “Agreement“) with the shareholders of Samurai Motion Tracking Corp. (“Samurai“) whereby the Company has agreed to acquire all of the issued and outstanding share capital of Samurai (the “Acquisition“). Headquartered in Vancouver, British Columbia, Samurai is a software-based vision therapy company providing computer aided vision therapy resources.

“This acquisition demonstrates Binovi’s commitment to continually evolve our technology offering with adoptable resources to our SaaS stack,” commented Adam Cegielski, Binovi CEO. “We are excited to bring the proven technology developed by Samurai to our growing user base of vision professionals, especially as we position ourselves for expansion into the K-12 education sector. Acquiring CAVT brings industry-recognized and relied-upon software to the Binovi Platform.”

About Samurai Computer Aided Vision Therapy

Originally created by Dr. Gary Vogel, Computer Aided Vision Therapy (CAVT) is an extensive software package for developing eye tracking skills, visual thinking & processing skills, and binocular vision skills. The CAVT suite consists of four primary modules: Track & Read, Visual Information Processing Skills (VIPS), Visual Thinking, and Computer Vergences. These modules include activities and exercises to be completed by patients using a computer, originally in an optometrist/vision therapy office setting, and later at home with data being reported manually to the patient’s care team

Terms of the Acquisition

In consideration for the Acquisition of all the issued and outstanding share capital of Samurai, the Company has agreed to pay an aggregate consideration of CDN$2,516,000.00 (the “Purchase Price“) payable by the issuance of 31,450,000 common shares of the company (the “Consideration Shares“) at a deemed price of CDN$0.08 per Consideration Share to the underlying shareholders of Samurai.

The Acquisition is subject to TSX Venture Exchange approval and the Company anticipates that the Acquisition will constitute an “Expedited Acquisition” under the policies of the TSX Venture Exchange. The Company may pay a finder’s fee in connection with the Acquisition and no new directors or officers will be added to the Company management team in connection with the Acquisition.

For additional information on the Company, please visit https://www.binovi.com/binovi-connect

@BinoviVISN – Twitter & Instagram

Read More: https://agoracom.com/ir/BinoviTechnologies/forums/discussion/topics/759214-binovi-to-acquire-computer-aided-vision-therapy-cavt/messages/2312378#message

CLIENT FEATURE: Binovi VISN.ca $BNVIF Sets Sights on Disrupting $600bn Sports Performance Market $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-AB at 5:51 PM on Tuesday, March 16th, 2021
This image has an empty alt attribute; its file name is 300-x-300.jpg

CLIENT FEATURE: Binovi Technologies (VISN: TSX-V) Sets Sights on Disrupting $600bn Sports Performance Market

Why VISN?

  • Binovi is well-positioned to further commercialize and capitalize on the massive demand for Vision Therapy and Training For Athletes and Education.
  • Strong IP Portfolio
  • 1 in 4 people on the planet have vision problems that go beyond simply not being able to read those letters on the wall and requiring a prescription.
  • Since the launch of Binovi, more than 800 organizations have been registered and have used the platform for vision therapy, sports vision performance.
  • Clients Include:
    • Dallas Stars (NHL)
    • Chicago Cubs (MLB)
    • Sporting KC (MLS)
    • Tennis Canada
    • Showcased During NFL Scouting Combine
  • Company’s Vision Therapy Products Used In:
    • Over 1,500 Practices
    • 20 Countries 
  • These organizations have created nearly 31,000 users and have completeded more than 400,000 active sessions centred around the Binovi Library list of activities, custom activities created by member organizations.
  • Flagship “Binovi” Is State-Of-The-Art Platform
    • Measures 14 Key Vision Skills
    • Essential For Maximizing Brain Performance
  • Signed Sports Vision Partnership With Eli Wilson Goaltending
    • World Leader In Goaltending Development
    • 600 Active Goaltending Camp Participants
    • 50,000 Global Aspiring Goaltenders
  • Announced a strategic partnership with STEM Sports
  • Expanded its global reseller network with a partnership with Sport-Orthèse, major European sports e-seller

Binovi Technologies – Vision Performance and Vision Therapy

Recent Highlights

Q3 2020 Financial Highlights:

  • Revenue increased by more than 100% in Q3 2020, in comparison to Q3 2019
  • A combined $3.12 Million raised through private placement subscriptions with strategic investors.

February:

  • Binovi Partners with European Reseller Sport-Orthese to Commercialize Binovi Hardware
    • This move demonstrates Binovi’s ongoing efforts to optimize its revenue opportunities within its global strategy.

January

  • Binovi Partners with STEM Sports(R) to Contribute to K-8 Curriculum that will be Binovi Connect Enabled
  • Binovi Technologies Q3 2020 Revenue Up, Increasing Top-Line and Gross Margin Results

Market Analysis

  • Sports Performance Market is a $600 Billion Opportunity
  • Vision Therapy captures 3% of a $36B Yearly Vision Market today.
  • Vision Therapy grew by 22% in 2020 and won 4% of the $39B Yearly Market in 2020 with organic growth.
  • VISN’s sights are set on disrupting the sports performance industry in 2021, as we receive engagement from leaders within the human performance – sports performance industry.
  • The size of the sports performance market reached a value of nearly $488.5B in 2018, having grown at a compound annual growth rate (CAGR) of 4.3% since 2014, and is expected to grow at a CAGR of 5.9% to nearly $614.1B by 2021.
VSN-Pic-2

What is VISN?

  1. Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance.
  2. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance.
  3. Binovi Technologies Corp (TSX-V: VISN | OTCQB: BNVIF) is reshaping V Education, Vision Care, and Performance through Purposeful, Powerful Vision Training
  4. Utilizing in-office and home-based activity protocols, the innovative Binovi platform helps optometric practices gain greater results, faster, with improved patient satisfaction in areas ranging from sports performance to binocular vision abnormalities.
  5. In a world in which competitors are seeking an edge, Binovi vision training develops faster brains to deliver that edge.
VSN-Pic-1

How Does VISN Work?

  1. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training.
  2. Binovi goes far beyond fixing eyes that simply can’t see a bunch of letters on an eye chart.  Rather, Binovi delivers higher-performing brains by optimizing the performance of the eyes. Binovi synchronizes your eyes and your brain to deliver maximum performance for athletes and students.
  3. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort.
VSN-Pic-3

Who Uses VISN?

Binovi is currently used in over 20 countries and supported by recognized optometry leaders.

  1. Patients: Optometrist-lead vision therapy for patients suffering from developmental issues or recovering from injury.
  2. Optometry Professionals: Practicing optometrists and vision therapists working in development, rehabilitation, and healthy ageing.
  3. Athletes: Optometry-backed tools to help improve sports vision performance indicators like reaction time and hand-eye coordination.
VISN-Pic-4

Binovi $VISN.ca $BNVIF

$EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Binovi Techologies Corp. is traded on the TSX.V as VISN.

For more information, visit: https://binovi.com/investors/

FULL DISCLOSURE: Binovi Technologies is an advertising client of AGORA Internet Relations Corp.

Binovi $VISN.ca $BNVIF Partners with European Reseller Sport-Orthese to Commercialize Binovi Hardware $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 9:11 AM on Thursday, February 11th, 2021
  • Announced that it has expanded its global reseller network with a partnership with Sport-Orthèse ( www.sport-orthese.com ), activating its country-specific scalable business model.
  • This move demonstrates Binovi’s ongoing efforts to optimize its revenue opportunities within its global strategy.

Toronto, New York – February 11, 2020 – Binovi Technologies Corp., (Binovi) (TSXV:VISN ) | ( OTC:BNVIF ) | ( GR:2EYA) today announces that it has expanded its global reseller network with a partnership with Sport-Orthèse ( www.sport-orthese.com ), activating its country-specific scalable business model. This move demonstrates Binovi’s ongoing efforts to optimize its revenue opportunities within its global strategy.

“As Binovi continues to successfully implement its global reseller partnerships, we remain dedicated to serving our consumers more personally and investing in the company’s long-term growth opportunities. In working with Sport-Orthèse, we’re signalling our dedication to our European clientele and furthering our goal for continued success on the continent” said Adam Cegielski, Binovi Founder + CEO.

Binovi remains firmly committed to serving users through its global partners with best-in-class product innovations and customer service while leveraging partnerships to support sustainable, profitable growth world-wide. In addition to this new connection to the EU, the Company will continue to work with existing distribution partner Bernell Corporation in the United States.

“We continue to broaden our customer base and aim to provide the best possible experience, especially with respect to working with customers in their native language whenever possible. Sport-Orthèse has the reach and capabilities to ensure Binovi is well represented in the European market,” commented Binovi Executive Chairman Terry Booth.

Read more: https://agoracom.com/ir/BinoviTechnologies/forums/discussion/topics/755170-binovi-partners-with-european-reseller-sport-orthese-to-commercialize-binovi-hardware/messages/2303213#message

Binovi $VISN.ca $BNVIF Partners with STEM Sports(R) to Contribute to Curriculum that will be Binovi Connect Enabled $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 9:08 AM on Thursday, January 28th, 2021
  • Announced a strategic partnership with STEM Sports® with the goal of contributing to a Binovi Connect enabled curriculum for their K-8 programs.
  • STEM Sports® provides a turnkey K-8 supplemental curriculum that uses sports as the real-life application to drive STEM-based learning in classrooms, after-school programs, and camps.
  • STEM Sports® programs are currently active in a variety of school districts within 49 of the 50 US states.

January 28, 2021 –  Toronto, New York – Binovi Technologies Corp., (Binovi) (TSXV:VISN ) | ( OTC:BNVIF ) | ( GR:2EYA), a leader in neuro-vision performance technology, is proud to announce a strategic partnership with STEM Sports® with the goal of contributing to a Binovi Connect enabled curriculum for their K-8 programs. STEM Sports® provides a turnkey K-8 supplemental curriculum that uses sports as the real-life application to drive STEM-based learning in classrooms, after-school programs, and camps. STEM Sports® programs are currently active in a variety of school districts within 49 of the 50 US states. Additionally, STEM Sports® has been awarded a STEM.org Accredited™ Educational Experience trustmark! STEM.org Educational Research is the longest operating, privately held, STEM education research and credentialing organization in America, serving over 4,500 schools, districts, and organizations in over 25 countries.

“Investing in STEM-focused or STEM-based programs has proven time and time again to be a powerful way for companies to give back and to help promote new avenues of thinking. With this partnership, Binovi is teaming up with an already strong group in STEM Sports® to develop an important set of skills that often go overlooked. We’re excited for how Jeff and his team will be able to improve the lives —in the classroom, on the field, and in everyday life— of these young minds,” said Adam Cegielski, Binovi Founder & CEO.

“We have and will continue to collaborate with partners that see the value in investing in the education of today’s students so that they can enhance the future workforce. Binovi literally sees the opportunity to enhance the technology aspects that we provide in our curricula to the benefit of K-8 schools and afterschool programs,” said Jeff Golner, STEM Sports® President & CEO.

There has been a significant influx of capital and concentration of efforts in STEM-related efforts, with grants from Disney putting $200,000 ( NYSE: DIS) into STEM programs in central Florida, tire manufacturing giants Goodyear celebrating 20 years of STEM education investment ( NASDAQ: GT ) and Bridgestone continuing their investment in a STEM-focused automotive training program (OTC US: BRDCY ) STEM-based automotive training programs at local colleges , and partnering with NFL star Larry Fitzgerald’s First Down Fund to provide underserved youth with the technology they need to facilitate their education.

“Using athletics as a vehicle for learning is a powerful way to instill real-life skills into young minds that will drive them to succeed both in the game and in life. By joining forces with STEM Sports®, we aim to open their student athletes’ eyes to these new skills, as well as tools to promote skill advancement and performance improvement that will serve them in the same way now and throughout their lives,” commented Tania Archer, Binovi Head of Commercialization & Strategic Partnerships.

Read more: https://agoracom.com/ir/BinoviTechnologies/forums/discussion/topics/754116-binovi-partners-with-stem-sports-r-to-contribute-to-curriculum-that-will-be-binovi-connect-enabled/messages/2300748#message

Binovi Technologies $VISN.ca $BNVIF Q3 2020 Revenue Up, Increasing Top-Line and Gross Margin Results $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 9:38 AM on Thursday, January 21st, 2021

Q3 2020 Financial Highlights:

  • Revenue increased by more than 100% in Q3 2020, in comparison to Q3 2019.
  • A combined $3.12 Million raised through private placement subscriptions with strategic investors.

January 21, 2021 – Toronto – Binovi Technologies Corp. (Binovi) (TSXV:VISN ) I ( OTC:BNVIF ) | ( GR:2EYA ) a leader in neuro-vision performance technology, reports results for the Company’s fiscal third quarter, ended November 30, 2020. The Company’s net sales results continue to be affected by the global health crisis. Increased demand for products across multiple categories led to an increase in top-line and gross margin results.

“Strategically positioned within telehealth, we believe the coming quarters will be pivotal in establishing our reputation and status as a competitor within this rapidly growing marketplace. While we are seeing strong growth across the business, it is important to recognize that we are making big investments in our people and infrastructure that are essential to support the significant growth that lies ahead. This includes big investments in our telehealth SaaS, our provider network, and personnel are critical as we scale the business,” stated Executive Chairman, Terry Booth.

Q3 2020 Financial Highlights:

  • Revenue increased by more than 100% in Q3 2020, in comparison to Q3 2019.
  • A combined $3.12 Million raised through private placement subscriptions with strategic investors.

Operational Highlights:

  • Since the launch of Binovi, more than 800 organizations have been registered and have used the platform for vision therapy and/or sports vision performance. These organizations have created nearly 31,000 users, together completing more than 400,000 active sessions centered around the Binovi Library list of activities, custom activities created by our member organizations.
  • Advanced the development of the company’s web-based telehealth SaaS, Binovi Connect. The beta launch of the platform is planned for Q1 2021.
  • Product marketing continues to grow brand awareness and promote sales, with an increase of 300% in website traffic, with improvements in direct media marketing and general top-of-mind awareness.

Read more: https://agoracom.com/ir/BinoviTechnologies/forums/discussion/topics/753563-binovi-technologies-q3-2020-revenue-up-increasing-top-line-and-gross-margin-results/messages/2299224#message

Binovi $VISN.ca $BNVIF Appoints Dr. Michael Gallaway to the Binovi Scientific Advisory Board $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 10:23 AM on Tuesday, December 22nd, 2020
  • Announced the appointment of Dr. Michael Gallaway to the Binovi Scientific Advisory Board. Dr. Galloway joins the other members of the board in directing the company’s advancements.
  • “We are very pleased to welcome Dr. Gallaway to the Scientific Advisory Board. His extensive experience working with children will help tremendously as we push Binovi into the education sector, with our focus on K-12 -and particularly K-3-students,” said Adam Cegielski, Binovi CEO.

TORONTO, ON and NEW YORK, NY / December 22, 2020 / Binovi Technologies Corp., (Binovi) (OTCQB:BNVIF) (TSX-V:VISN) (GR:2EYA) is proud to announce the appointment of Dr. Michael Gallaway to the Binovi Scientific Advisory Board. Dr. Galloway joins the other members of the board in directing the company’s advancements.

“We are very pleased to welcome Dr. Gallaway to the Scientific Advisory Board. His extensive experience working with children will help tremendously as we push Binovi into the education sector, with our focus on K-12 -and particularly K-3-students,” said Adam Cegielski, Binovi CEO.

“I am delighted that Dr. Gallaway has joined our Scientific Advisory Board”, commented Dr. Leonard Press, Binovi Chief Scientific Officer. “His background in scientific research, vision-based learning problems, vision screening, and concussion management, will help take Binovi to another level.”

“I look forward to joining Binovi’s Scientific Advisory Board especially as the company is targeting more advanced school screening protocols and interventions for children,” said Dr. Gallaway, Binovi Scientific Advisory Board Member.

About Dr. Michael Gallaway

Dr. Gallaway is board certified in vision therapy as a Fellow in the College of Optometrists in Vision Development (COVD), and is a Fellow in the American Academy of Optometry (AAO). He has been in private practice in the South Jersey area since 1989, specializing in vision therapy and children’s vision disorders. He is also an Associate Professor at the Pennsylvania College of Optometry at Salus University in Philadelphia. In addition to his teaching, he is involved in research in learning related vision problems, amblyopia, vision therapy for convergence insufficiency, and concussion-related vision problems. He has published many articles in optometric journals and has lectured extensively in the US and internationally on children’s vision and vision therapy.

Dr. Gallaway was the Principal Investigator at Salus/PCO for CITT-ART, a National Eye Institute funded nationwide study assessing the impact of vision therapy for convergence insufficiency on reading and attention. In 2015, Dr. Gallaway received the Skeffington Award for Excellence in Optometric Writing from the College of Optometrists in Vision Development in recognition of his scholarly writing and research over his career. Dr. Gallaway was also the Principal Investigator at Salus University for the Convergence Insufficiency Treatment Trial (CITT), an NIH funded randomized multicenter clinical trial that was published in 2008.

Dr. Gallaway was also an Investigator both in his office and at Salus University for the Pediatric Eye Disease Investigator Group (PEDIG) studying the Amblyopia Treatment Studies, which Dr. Gallaway has participated in from 2001 to 2019.

For additional information on the Company, please visit https://www.binovi.com/binovi-connect

@BinoviVISN – Twitter & Instagram

About Binovi Connect

Binovi is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. As a SAAS based solution, the Binovi Connect App is supported by specialized expert knowledge, unique data insights and supporting hardware to deliver customized, one-on-one cognitive training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Binovi is currently used in over 20 countries.

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO

Dr. Leonard Press
Chief Scientific Officer

Investor Relations

Email: [email protected]
Toll-free: 1 (844) 866-6162
https://www.binovi.com/investor-reports/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Binovi Technologies Corp.

Binovi $VISN.ca $BNVIF Announces Election of Directors and Annual General and Special Meeting Results $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 5:05 PM on Friday, December 18th, 2020
  • Announced the results from the Annual General and Special Meeting of Shareholders of the Company
  • Held on December 16, 2020 at 11:00 a.m. PST at its registered and records office located Suite 3123 – 595 Burrard Street, Vancouver, BC, and by conference call.

TORONTO, ON / December 18, 2020 / Binovi Technologies Corp. (“Binovi” or the “Company”) (TSX-V:VISN I OTCQB:BNVIF | FRA:2EYA) a leader in neuro-vision performance technology, is pleased to announce the results from the Annual General and Special Meeting of Shareholders of the Company (the “Shareholders”), held on December 16, 2020 at 11:00 a.m. PST at its registered and records office located Suite 3123 – 595 Burrard Street, Vancouver, BC, and by conference call.

All nominees listed in the information circular dated November 9, 2020 (the “Circular”) were elected as directors of the Company, with the resulting directors being:

Mr. Terry Booth;

Mr. Adam Cegielski,

Mr. Sean Charland;

Mr. Patrick Morris; and

Mr. Salim Mithani.

In addition, the Shareholders received the audited annual financial statements of the Company for the year ended February 29, 2020 and approved all of the other resolutions detailed in the Circular and put forward at the Meeting, namely:

  1. To fix the number of directors to be elected for the ensuing year at five (5);
  2. To elect directors of the Company for the ensuing year;
  3. To appoint the auditors for the Company for the ensuing year and authorize the Directors to fix the auditors’ remuneration;
  4. To consider and pass an ordinary resolution to reapprove the Company’s rolling stock option plan; and
  5. To approve an amendment to stock options granted to insiders of the Company;

For additional information on the Company, please visit https://www.binovi.com/binovi-connect.

@BinoviVISN – Twitter & Instagram

About Binovi Connect

Binovi is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet, or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time and with less effort. As a SAAS based solution, the Binovi Connect App is supported by specialized expert knowledge, unique data insights, and supporting hardware to deliver customized, one-on-one cognitive training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Binovi is currently used in over 20 countries.

On behalf of the Board of Directors

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO

Investor Relations
Email: [email protected]
Toll-free: 1 (844) 866-6162

Forward-looking information:
Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates, and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com. The Company undertakes no obligation to update these forward-looking statements other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

SOURCE: Binovi Technologies Corp.

Binovi Technologies $VISN.ca $BNVIF To Host Annual General Meeting and Investors Conference Call $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 11:05 AM on Wednesday, December 16th, 2020
  • Hosting a conference call, today, December 16, 2020 in order to conduct its Annual General Meeting, and for interested investors.
  • The formal part of the AGM will take approximately ten minutes followed by an update to investors and shareholders on the Company’s operations.
  • Binovi CEO, Adam Cegielski, will host the call and answer questions from participants.

TORONTO, ON / December 16, 2020 / Binovi Technologies Corp. (Binovi) (OTCQB:BNVIF)(TSX-V:VISN)(FRA:2EYA) is hosting a conference call, today, December 16, 2020 in order to conduct its Annual General Meeting, and for interested investors. The formal part of the AGM will take approximately ten minutes followed by an update to investors and shareholders on the Company’s operations. Binovi CEO, Adam Cegielski, will host the call and answer questions from participants.

Conference Call:

Date: Wednesday, December 16, 2020
Time: 11:15am PST, 2:15pm EST
Dial-in: Tollfree – 1 (866) 365 4406. Passcode: 6096110#

For additional information on the Company, please visit https://www.binovi.com/binovi-connect

@BinoviVISN – Twitter & Instagram

About Binovi Connect

Binovi is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. As a SAAS based solution, the Binovi Connect App is supported by specialized expert knowledge, unique data insights and supporting hardware to deliver customized, one-on-one cognitive training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Binovi is currently used in over 20 countries.

On behalf of the Board of Directors

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO

Investor Relations
Email: [email protected]
Toll-free: 1 (844) 866-6162
https://www.binovi.com/investor-reports

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

MEDIA: The doctor will stream you now: How Binovi $VISN.ca $BNVIF is leading the charge in virtual vision therapy $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 4:27 PM on Tuesday, December 15th, 2020
  • The pandemic has created a new consumer expectation for virtual services
  • Tech company Binovi gives optometry patients a new alternative
  • With Binovi Connect, the company has created a seamless network for vision care professionals to work together

With 2020 becoming the year of the homebody, we’ve all had to drastically reduce our trips out of the house. While it’s been hard on everyone, we can consider ourselves lucky that there were already numerous resources to ease the transition into sheltering in place.

It’s no secret that companies bridging the distance between services like food delivery apps, and 24-hour product distribution have been the trend for a while now. Still, with communities shutting down, many newer services crossed the line from following the trend into being embedded into daily life.

While things like Zoom conferences and virtual personal training have been an infrequent occurrence pre-pandemic, consumers have realized that they’re now mainstream and accepted options to save time and social distance.

Office groups are even doing video-streamed murder mystery parties in place of their traditional in-person Christmas gatherings. It’s a new language of behaviour that we’re becoming fluent in as we continue to adapt to how COVID has changed our lives.

Even as restrictions lift and the curve eventually flattens, it’s hard to see a future without these new tools at consumers’ disposal. For instance, who would want to go back to sitting in a crowded waiting room, when you could simply have an online conference with your doctor? This Binovi Platform allows users to browse from a list of Binovi Providers, schedule appointments, conduct screening, and more.

It’s a shift that has already changed the healthcare industry. Specialist professionals can now maximize their patient schedule and keep appointments as socially distanced as possible. While it’s a handy change of pace, there has already been an opportunity to create a more accessible network to maximize efficiency and accuracy for both doctors and patients.


“Once a training regimen is established, along with a schedule for check-ins and evaluations, users can conduct their own training sessions.”

— Adam Cegielski, CEO, Binovi Technologies Corp.


Binovi offers the patient management resource that medical professionals have been waiting for

With one in four people worldwide living with issues related to vision that go beyond visual acuity, it’s time to address this gap and come up with an effective and efficient way for specialists to meet with patients during the pandemic and beyond.

Enter Binovi Technologies (TSXV: VISN | OTCQB: BNVIF), a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance.

Established to enhance how optometrists work with their patients and bring treatment into the 21st century, Binovi is supported by recognized optometry leaders worldwide.

This connection to vision therapists, occupational therapists, and physical therapists has led the company towards innovative testing methods that patients can do remotely. While in the presence of a professional, patients produce quantifiable data that Binovi can analyze, consult with other professionals about, and recommend the next steps for treatment.

Binovi’s experience with facilitating a channel between professionals and patients has led to the company’s latest telehealth innovation, Binovi Connect, which is a web-based video conferencing solution that connects consumers to vision care professionals focused on concussions, reading skills, and athletic enhancement.

The new application not only gives a straightforward service to both parties, but it provides a network for professionals to consult and collaborate with each other about specific patient treatments. It’s a streamlining of service that gives clarity and peace of mind to anyone who has felt like they might not have grasped everything their doctor has just said.

Patients can easily choose from specialists who best meet their needs, establish a routine with their selected one, and monitor in real-time the results they’ve made. On the other side of things, doctors can see notes from other professionals and collaborate on multiple fronts to create multi-tiered treatment tactics for shared patients.

It’s a program that has countless applications in the healthcare world, but for the moment, Binovi is remaining focused on vision-based therapy. With 800 clinics across the globe already using Binovi’s systems, their market share of the $74 billion a year Visioncare industry will only grow.
 

To do that, the company emphasizes the program’s ease of use and a clear value proposition. Binovi Connect is incredibly user-friendly, and patients are given everything they need to create progress.

“Once a training regimen is established, along with a schedule for check-ins and evaluations, users can conduct their own training sessions,” says Cegielski.

“This is happening while still under the watchful eye of their healthcare professionals who can monitor the results with session data stored in the cloud.”

Since the launch of this platform, the 800 organizations have created nearly 31,000 users, together completing more than 400,000 active sessions centered around the Binovi Library list of activities.

Niche treatments for niche ailments

When it comes to niche treatments, Binovi offers patients the materials they need as recommended by each doctor for treatment. This could be equipment for equilibrium building exercises or the means to conduct a supervised vision test.

Binovi Coach encourages and empowers patients to confidently complete their prescribed home therapy with clarity and guidance.

The insights from these sessional treatments are then boosted by the program’s AI. Cloud-based session data is effectively merged with data from the clinicians’ past findings, then offered to each patient’s current therapist. This allows each session to produce real-time suggestions, and present immediate resources to each therapist.

It’s a groundbreaking new approach to treatment, that has produced startling results for patients suffering from concussions, binocular vision dysfunction, amblyopia, and countless other afflictions. With Binovi, patients can actively improve dynamic visual acuity, visual reaction time, depth perception, and hand-eye/body-eye coordination.

The framework is already in place for patients to receive the specialized care they need regardless of geography or time zone. Now, it’s just a matter of time before consumer standards for virtual appointments and personal care reach a tipping point. Determining whether someone needs vision therapy, or could benefit from vision training, can start early.

When that happens, Binovi is ready to serve.

So, what’s next for the platform?

  • Migrating offline sessions to Binovi Connect
  • Inclusion of a broader class of providers
  • Support for more languages
  • Release of SDK for integration with other platforms
  • Anonymized data access for research
  • Expecting to launch a Beta version of the app by fiscal Q1 2021

“We are excited to continue to build out a robust telehealth platform as we continue our mission to be the leader in neuro-vision performance technology space.”

Why should investors take note of Binovi?

Binovi’s future innovation opportunities are largely driven by identifying high-value client needs and evaluating each unique opportunity to develop new products and services in the areas of neurotechnology and vision training to support unlocking human performance.

The company’s future innovation pipeline looks like this:

  • Expanding its capabilities within the education sector
  • Partnering with elite athletes, professional sports as well as esports teams
  • Standardizing data collection in the field to create optimized training regimens based on unique profiles, peer groups and custom goals
  • Working with military and law enforcement
  • Treating the aging population and improving performance for those affected by the impact of brain-related diseases or natural aging

Binovi’s innovation milestones from first acquiring Wayne Engineering in 2015 and its educational IP to commercializing its Binovi Connect Platform.

Additionally, the acquisition and integration of the VIMA Rev Strobe Lenses under the Binovi umbrella has provided Binovi with an additional toolset to expand its offering. Developed by Nike’s former Global Director of Vision Science and his team of sport science experts, the VIMA Rev Strobe Lenses are an integrated strobe training system that stimulates neuro-cognition through vision training.

VIMA’s technology is being integrated into Binovi’s product platform, with several orders already fulfilled. Current VIMA Rev strobe users include the NHL’s Colorado Avalanche, the NBA’s Golden State Warriors, Chicago Bulls and the Milwaukee Bucks.

Binovi has had a tremendous year so far, and they’re not done yet.

To learn more about the company, visit their website here.

Follow Binovi Technologies on social media:

Facebook
Twitter
LinkedIn
Instagram

Source: https://www.bnnbloomberg.ca/the-doctor-will-stream-you-now-how-binovi-is-leading-the-charge-in-virtual-vision-therapy-1.1536215

AGORACOM Small Cap 60: Binovi Technologies $VISN.ca $BNVIF A Step Ahead In Correcting Vision $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 12:44 PM on Wednesday, December 9th, 2020

Executive Chairman, Terry Booth describes Binovi Technologies (VISN:TSXV) (BNVIF:OTCQB) as “A step ahead in correcting vision. Mr Booth points out that 20/20 vision does not guarantee great binocular vision. He continues to mention that utilizing vision therapy is often highly effective in correcting any deficiencies in Binocular vision. This therapy can be highly advantageous for children especially in the early elementary years.

Hub On AGORACOM / Corporate Profile